Price Alert

Innate Pharma S.A. (IPHA)

NASDAQ: IPHA · Real-Time Price · USD

2.11

-0.07 (-3.21%)

At close: Aug 15, 2025, 3:59 PM

2.12

0.47%

After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021
Revenue	12.62M	33.79M	56.79M	43.65M	49.58M	44.06M	12.11M	36.31M
Cost of Revenue	n/a	53.65M	40.3M	29.08M	25.83M	25.38M	23.5M	15.26M
Gross Profit	12.62M	-19.86M	16.49M	14.57M	23.75M	18.69M	-11.39M	21.05M
Operating Income	-51.58M	-38.58M	-17.52M	-34.06M	-24.63M	-26.73M	-57.48M	-43.99M
Interest Income	2.64M	14.48M	12.9M	1.31M	350K	4K	7.5K	32K
Pretax Income	-49.47M	-34.05M	-12.42M	-71.25M	-66.01M	-27.31M	-58.07M	-89.19M
Net Income	-49.47M	-34.05M	-7.57M	-62.69M	-58.1M	-22.79M	-52.81M	-77.37M
Selling & General & Admin	11.93M	18.73M	17.69M	18.11M	20.94M	16.88M	18.89M	29.44M
Research & Development	51.98M	53.65M	52.98M	53.57M	48.84M	49.49M	46.13M	42.11M
Other Expenses	283K	-29.08M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	64.2M	17.64M	45.01M	71.68M	69.78M	66.37M	65.02M	71.55M
Interest Expense	634K	3.62M	3.35M	418K	94K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	338K	245K	148.5K	265K	326.5K	196.5K	222K
Cost & Expenses	64.2M	71.28M	73.22M	77.71M	74.21M	70.79M	69.59M	80.3M
Income Tax Expense	n/a	-9.75M	-14.6M	-8.62M	-8.04M	-11.93M	-12.59M	-11.82M
Shares Outstanding (Basic)	81.05M	79.88M	80.59M	80.32M	80.19M	79.74M	79.54M	79M
Shares Outstanding (Diluted)	81.05M	80.87M	80.59M	83.78M	80.19M	81.87M	79.54M	79M
EPS (Basic)	-0.61	-0.43	-0.09	-0.78	-0.72	-0.29	-0.67	-0.98
EPS (Diluted)	-0.61	-0.43	-0.09	-0.78	-0.72	-0.29	-0.67	-0.98
EBITDA	-46.91M	-35.96M	-9.56M	-64.81M	-59.42M	-20.69M	-51.29M	-78.19M
EBIT	-48.91M	-38.58M	-15.08M	-15.27M	-8.21M	-25.04M	-57.76M	-88.84M
Depreciation & Amortization	1.99M	2.62M	5.52M	6.03M	4.42M	4.42M	4.57M	8.76M